Prostate Cancer Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with a new (not previously treated) high-risk prostate cancer that has not spread to other parts of the body, confirmed by a tissue sample (biopsy)
• People whose cancer meets at least one of the following high-risk features: the tumour has grown beyond the prostate based on physical examination and/or MRI scan; the cancer cells look very abnormal under a microscope (aggressiveness score of 4 or higher on a specialist grading scale); or a prostate-specific antigen (PSA) blood test result above 20 ng/mL at the time of diagnosis
• People who are well enough to receive either robotic surgery or radiation therapy (with or without hormone therapy), based on a standard health fitness scale (score of 0 or 1)
• People who are living in the Netherlands
• People who are able to read and understand Dutch

Who may not be able to join:

• People whose prostate cancer is a type other than the most common form (adenocarcinoma)
• People who were diagnosed or treated at a hospital outside the Netherlands
• People whose initial treatment plan includes a specific type of hormone therapy known as androgen receptor targeted agents (ARTA)

Important: Always verify eligibility with the trial site directly before applying.